top of page

RUSSIA: LIFE-CYCLE INSIGHTS


IPD’s Russian subscription brings transparency to this highly
complex and unique market, offering:
​
-
Easy-to-use Russian brand,
biosimilar, and generic drug
launch tracking schedules
​
-
Russian litigation tracking and
in-the-courtroom coverage with
real-time updates
​
-
Personalized consults with local Russian intellectual property analysts​
​
-
Weekly updates including trending Russian drug topics, recent publications, and​
loss-of-exclusivity information
​​
-
Comprehensive Russian clinical development tracking in every major disease class
-
Complete drug information with locally reviewed Russian indications
​
-
Russian API (DMF) information
bottom of page